Santa Barbara Asset Management LLC lifted its position in Johnson & Johnson (NYSE:JNJ) by 0.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,091,102 shares of the company’s stock after purchasing an additional 2,301 shares during the quarter. Johnson & Johnson comprises about 2.3% of Santa Barbara Asset Management LLC’s holdings, making the stock its 26th biggest holding. Santa Barbara Asset Management LLC’s holdings in Johnson & Johnson were worth $141,854,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently made changes to their positions in JNJ. Harding Loevner LP acquired a new position in Johnson & Johnson in the second quarter valued at about $106,000. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its position in Johnson & Johnson by 29.9% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock valued at $115,000 after buying an additional 200 shares during the last quarter. Mountain Capital Investment Advisors Inc acquired a new position in Johnson & Johnson in the second quarter valued at about $124,000. Shine Investment Advisory Services Inc. acquired a new position in Johnson & Johnson in the second quarter valued at about $177,000. Finally, Lenox Wealth Management Inc. lifted its position in Johnson & Johnson by 1.7% in the second quarter. Lenox Wealth Management Inc. now owns 1,457 shares of the company’s stock valued at $193,000 after buying an additional 24 shares during the last quarter. 67.35% of the stock is owned by hedge funds and other institutional investors.
A number of research firms have commented on JNJ. Jefferies Group set a $165.00 target price on shares of Johnson & Johnson and gave the company a “buy” rating in a research report on Monday, February 26th. Citigroup reduced their price target on shares of Johnson & Johnson from $150.00 to $146.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 27th. Vetr raised shares of Johnson & Johnson from a “buy” rating to a “strong-buy” rating and set a $152.28 price target on the stock in a research report on Monday, February 5th. Stifel Nicolaus increased their price target on shares of Johnson & Johnson from $142.00 to $145.00 and gave the stock a “hold” rating in a research report on Wednesday, January 24th. Finally, BTIG Research reissued a “sell” rating and set a $110.00 price target on shares of Johnson & Johnson in a research report on Wednesday, January 24th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $146.26.
Shares of Johnson & Johnson (NYSE JNJ) opened at $132.63 on Tuesday. The firm has a market cap of $358,972.31, a P/E ratio of 18.33, a P/E/G ratio of 2.19 and a beta of 0.77. Johnson & Johnson has a 1-year low of $120.95 and a 1-year high of $148.32. The company has a quick ratio of 1.12, a current ratio of 1.41 and a debt-to-equity ratio of 0.51.
Johnson & Johnson (NYSE:JNJ) last issued its earnings results on Tuesday, January 23rd. The company reported $1.74 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.72 by $0.02. The firm had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.08 billion. Johnson & Johnson had a net margin of 1.70% and a return on equity of 29.00%. The firm’s revenue was up 11.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.58 earnings per share. equities analysts forecast that Johnson & Johnson will post 8.11 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Tuesday, February 27th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Monday, February 26th. This represents a $3.36 annualized dividend and a yield of 2.53%. Johnson & Johnson’s dividend payout ratio (DPR) is 861.54%.
TRADEMARK VIOLATION NOTICE: This article was first posted by American Banking News and is the property of of American Banking News. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://www.americanbankingnews.com/2018/03/13/santa-barbara-asset-management-llc-has-141-85-million-position-in-johnson-johnson-jnj.html.
Johnson & Johnson Company Profile
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.